Women’s health is a historically overlooked area of the healthcare sector. For decades, studies have prioritized male participants, and targeted women’s health solutions have been difficult to find. This trend has begun to change in recent years, especially in one area: technology.
Here is a quick look at recent developments in women’s health tech and how it is setting up a critical area of the health and wellness world for success moving forward.
The Women’s Health Gap
We live in an age of personalized health solutions. Many of TruLife Distribution’s partners thrive in niche markets — including women’s health. Yet, targeted answers to women’s health concerns are a relatively recent development.
This disparity in options between women and men affects everything, from initial research to access to quality care. The World Economic Forum highlights several critical conditions that highlight the issue, including:
- Endometriosis
- Autism and ADHD
- Cardiovascular disease and heart attacks
- Autoimmune conditions
- Antimicrobial resistance
McKinsey Health Institute adds the important distinction of “health spans” (the time someone is healthy) as opposed to “life spans” (the time someone is alive). Women spend an average of nine years in poor health, impacting their ability to be present and effective at work, at home, and in their communities.
The research and consulting firm adds that investments targeting the health issues at the core of this health gap could also boost the global economy by as much as $1 trillion dollars in the next 15 years. From individuals to businesses to friends, families, and communities, closing the Women’s Health Gap has benefits for all parties involved.
The question is, what are business owners and investors in the health sector doing about it?
The Emerging Investment in Women’s Health
The healthcare sector has woken up to the disparity in women’s health solutions, and investments are ramping up, especially in the area of women’s health technology, commonly called FemTech.
One report from Deloitte earlier in 2024 analyzed US health tech investment trends and found that there was a 5% increase in investments in this sector between 2022 and 2023. During that same time, broader investment in the health tech market dropped by 27%.
The 32% difference in growth rate seems to reflect a genuine changing in attitude among investors. They are waking up to the fact that this nearly four billion-person market is underserved and full of potential.
Another report from Keiser University Graduate School found that this investment in FemTech is already bearing fruit, from advanced screening methods to non-invasive prenatal testing, telehealth, wearable tech, and more.
As is the case everywhere else, artificial intelligence is also having an impact. AI is helping with predictive analytics, improved diagnostics, virtual health assistants, and personalized treatment plans.
The Rise of FemTech and the Spotlight on Women’s Health
2025 is set to be a year where women’s health shines. While FemTech is taking center stage, it isn’t the only area of the healthcare marketplace that is thriving. The team at TruLife Distribution has also seen an increase in demand for holistic, preventative, natural solutions that target women’s health. We expect to see that demand grow.
If you are a supplement manufacturer or health and wellness company with products that focus on feminine health, and you want to take advantage of the growing opportunities, reach out for a free consultation. It doesn’t matter if you’re a domestic company trying to expand or an international one attempting to enter the market. Our experienced team can help you create a plan to ensure you’re at the forefront of this transformative time in health and wellness history.
